Reinhart Partners LLC. lessened its position in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS – Free Report) by 44.0% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 928,660 shares of the semiconductor company’s stock after selling 729,085 shares during the quarter. Axcelis Technologies comprises 4.0% of Reinhart Partners LLC.’s portfolio, making the stock its 3rd biggest holding. Reinhart Partners LLC.’s holdings in Axcelis Technologies were worth $175,938,000 at the end of the most recent reporting period.
A number of other large investors have also added to or reduced their stakes in ACLS. REAP Financial Group LLC purchased a new stake in shares of Axcelis Technologies during the 4th quarter worth approximately $25,000. EverSource Wealth Advisors LLC grew its holdings in shares of Axcelis Technologies by 145.1% in the second quarter. EverSource Wealth Advisors LLC now owns 451 shares of the semiconductor company’s stock valued at $31,000 after purchasing an additional 267 shares in the last quarter. Advisory Services Network LLC purchased a new position in shares of Axcelis Technologies in the third quarter valued at $32,000. Leonteq Securities AG purchased a new position in shares of Axcelis Technologies in the fourth quarter valued at $40,000. Finally, Clearstead Advisors LLC increased its position in Axcelis Technologies by 197.1% in the fourth quarter. Clearstead Advisors LLC now owns 719 shares of the semiconductor company’s stock worth $58,000 after purchasing an additional 477 shares during the last quarter. Institutional investors own 89.98% of the company’s stock.
Axcelis Technologies Price Performance
Shares of Axcelis Technologies stock opened at $140.27 on Friday. The stock has a market cap of $4.31 billion, a price-to-earnings ratio of 47.07, a price-to-earnings-growth ratio of 9.68 and a beta of 1.92. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.99 and a current ratio of 4.90. The stock has a 50 day moving average price of $152.46 and a 200-day moving average price of $124.32. Axcelis Technologies, Inc. has a one year low of $73.60 and a one year high of $193.78.
Analysts Set New Price Targets
A number of equities research analysts recently issued reports on ACLS shares. Zacks Research raised shares of Axcelis Technologies from a “strong sell” rating to a “hold” rating in a research note on Monday, April 20th. B. Riley Financial raised shares of Axcelis Technologies from a “neutral” rating to a “buy” rating and set a $150.00 price objective for the company in a research note on Monday, April 20th. Craig Hallum downgraded shares of Axcelis Technologies from a “buy” rating to a “hold” rating and set a $140.00 target price on the stock. in a report on Friday. Weiss Ratings cut shares of Axcelis Technologies from a “hold (c)” rating to a “hold (c-)” rating in a research report on Tuesday, May 12th. Finally, Bank of America increased their price target on shares of Axcelis Technologies from $130.00 to $156.00 and gave the company an “underperform” rating in a report on Tuesday, June 23rd. Three equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $132.20.
Check Out Our Latest Report on ACLS
Insider Buying and Selling at Axcelis Technologies
In other news, Director John T. Kurtzweil sold 3,500 shares of the firm’s stock in a transaction dated Tuesday, May 19th. The shares were sold at an average price of $138.79, for a total value of $485,765.00. Following the completion of the sale, the director owned 32,990 shares in the company, valued at approximately $4,578,682.10. This trade represents a 9.59% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Gregory B. Graves sold 3,225 shares of Axcelis Technologies stock in a transaction dated Tuesday, May 19th. The stock was sold at an average price of $141.61, for a total transaction of $456,692.25. Following the transaction, the director directly owned 5,473 shares of the company’s stock, valued at approximately $775,031.53. This represents a 37.08% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 26,083 shares of company stock valued at $4,001,032. Insiders own 0.49% of the company’s stock.
Trending Headlines about Axcelis Technologies
Here are the key news stories impacting Axcelis Technologies this week:
- Positive Sentiment: Q2 earnings and revenue beat estimates. Axcelis reported revenue of $215.2 million, up 10.6% year over year, while non-GAAP diluted EPS was $1.06 versus the $0.89 consensus estimate. Non-GAAP gross and operating margins were 42.7% and 14.7%, respectively. Axcelis Announces Financial Results for Second Quarter 2026
- Positive Sentiment: Q3 guidance exceeded analyst expectations. Management forecast EPS of approximately $1.11 and revenue of $230 million, above consensus estimates of $1.01 and $214.8 million. The company also raised its full-year 2026 outlook to mid-single-digit revenue growth, improving visibility for investors. Axcelis expects Q3 2026 EPS of about $1.11 as it lifts full-year 2026 outlook
- Neutral Sentiment: Investors are weighing the semiconductor capital-spending outlook. Recent analysis highlights Axcelis’s exposure to the ongoing chip-manufacturing buildout but questions whether the equipment-spending cycle can continue supporting growth. This remains an important longer-term factor for ACLS. Can Axcelis Technologies Keep Riding the Semiconductor Capital Spending Wave?
- Negative Sentiment: Craig Hallum downgraded ACLS from Buy to Hold and assigned a $140 price target, suggesting limited near-term upside at the time of the report. The downgrade may temper enthusiasm following the earnings beat, particularly given the stock’s elevated valuation and recent volatility. Finviz
About Axcelis Technologies
Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.
The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.
Featured Articles
- Five stocks we like better than Axcelis Technologies
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Want to see what other hedge funds are holding ACLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axcelis Technologies, Inc. (NASDAQ:ACLS – Free Report).
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
